Identification of Early Markers of Response and Resistance to Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
Interventions: OTHER: Blood test
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Collaborators: European Commission